ArticleEuropean radiology2026
Bilateral distal femoral sclerotic lesions in elderly women: a distinct benign imaging pattern associated with fat necrosis and dystrophic calcification.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo characterize a previously unreported pattern of bilateral distal femoral sclerotic lesions in elderly women and to describe its radiographic, CT, MRI, and histopathologic features. MATERIALS AND
methodsThis retrospective study included patients with bilateral distal femoral sclerotic lesions identified on knee radiographs between 2018 and 2023. Lesions related to known skeletal disorders were excluded. Two musculoskeletal radiologists independently assessed lesion location and morphology. Available CT, MRI, and histopathologic findings were reviewed. Clinical and laboratory data were compared with age-matched controls. Interobserver agreement was assessed using Cohen's κ.
resultsThirty women (mean age, 76.7 ± 7.7 years) were included, with 60 knee radiographs, 13 CT scans, 10 MRI examinations, and one histopathologic specimen. On radiographs, sclerotic changes were exclusively lateral in 40%, predominantly lateral in 33.3%, and central in 26.7% of knees. Lesion morphology was linear (36.7%), nodular (10%), popcorn-like (8.3%), or mixed (45%), with almost perfect interobserver agreement (κ ≥ 0.88, p < 0.0001). MRI demonstrated a reticulonodular fibrous-like pattern aligned with the trabeculae within fat-like marrow signal intensity on T1- and T2-weighted images. Histopathologic examination of a surgically sampled similar tibial lesion demonstrated necrotic adipocytes with interstitial dystrophic calcification, without extensive trabecular bone formation or osteonecrosis. Clinical and laboratory parameters did not differ between patients and controls.
conclusionBilateral distal femoral sclerotic lesions associated with fat necrosis and dystrophic calcification may represent a distinct benign imaging pattern in elderly women. Further studies are needed to determine whether recognition of this bilateral pattern may avoid unnecessary investigations. KEY POINTS: QuestionDo bilateral distal femoral sclerotic lesions in elderly women represent a distinct benign imaging pattern? FindingsIn 30 elderly women, bilateral distal femoral sclerotic lesions exhibited a consistent imaging pattern without aggressive features. MRI revealed a reticulonodular fibrous-like pattern within a background of fat-like marrow signal on T1-weighted images. Clinical relevanceRecognition of the characteristic bilateral distribution and benign imaging features may help avoid unnecessary follow-up examinations or biopsies.
Indexed as
Identifiers
42844396What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.